Literature DB >> 12538124

Is hybrid coronary revascularization favored by cardiologists or cardiac surgeons?

Giuseppe D'Ancona1, Thomas A Vassiliades, W Douglas Boyd, Harry W Donias, Kenneth D Stahl, Hratch Karamanoukian.   

Abstract

We investigated the present use of integrated coronary revascularization (ICR) by interviewing a sample of United States invasive cardiologists and cardiac surgeons. Both groups still favor left internal mammary artery (LIMA) grafting to revascularize the left anterior descending (LAD) coronary artery. There remains a lack of exposure to and acceptance of ICR, especially for surgeons. We report the findings of this national survey of 180 cardiologists and 160 surgeons, as they may serve as an indicator of the current opinions about ICR and its future applicability as a standard method of coronary artery revascularization. We discuss the limited popularity of minimally invasive hybrid procedures and the importance of further exposing cardiologists and surgeons to ICR.

Entities:  

Mesh:

Year:  2002        PMID: 12538124

Source DB:  PubMed          Journal:  Heart Surg Forum        ISSN: 1098-3511            Impact factor:   0.676


  4 in total

1.  Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes.

Authors:  Barry Reicher; Robert S Poston; Mandeep R Mehra; Ashish Joshi; Patrick Odonkor; Zachary Kon; Peter A Reyes; David A Zimrin
Journal:  Am Heart J       Date:  2008-03-05       Impact factor: 4.749

2.  What the surgeon needs to know about percutaneous coronary intervention treatment of chronic total occlusions.

Authors:  Satoru Mitomo; Ozan M Demir; Antonio Colombo; Sunao Nakamura; Alaide Chieffo
Journal:  Ann Cardiothorac Surg       Date:  2018-07

3.  Hybrid coronary revascularization for the treatment of multivessel coronary artery disease.

Authors:  Michael O Kayatta; Michael E Halkos; John D Puskas
Journal:  Ann Cardiothorac Surg       Date:  2018-07

4.  Hybrid approach for complex coronary artery and valve disease: a clinical follow-up study.

Authors:  J O J Peels; G A J Jessurun; P W Boonstra; T Ebels; D J van Veldhuisen; I C C van der Horst; F Zijlstra
Journal:  Neth Heart J       Date:  2007       Impact factor: 2.380

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.